Clinical Trial Update: A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial of MM-121 with chemotherapy versus chemotherapy alone in heregulin-positive non-small cell lung cancer has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• MM-121 (seribantumab)

Snippet

Sponsor: Elevation Oncology | Conditions: Non-Small Cell Lung Cancer, NSCLC | Phase 2 | Status: TERMINATED | Results posted: 2021-10-12